Empirical Financial Services, LLC d.b.a. Empirical Wealth Management

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1510434 Seattle, WA

Back to ACAD Full portfolio

Position in ACAD

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$287,665

+$23,317 QoQ

Shares Held

12,923

+30.6% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 95.88330882921923.ToString("F0")% Shared 0.ToString("F0")% None 4.116691170780778.ToString("F0")%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Empirical Financial Services, LLC d.b.a. Empirical Wealth Management holds $8,046,747 across 13 Biotechnology names. ACAD ranks #8 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc.	66,223	$1,639,680
2	INBX	Inhibrx Biosciences, Inc.	22,584	$1,518,322
3	JAZZ	Jazz Pharmaceuticals plc	5,665	$1,070,968
4	PTCT	Ptc Therapeutics, Inc.	13,851	$943,667
5	ORKA	Oruka Therapeutics, Inc.	18,229	$894,131
6	EXEL	Exelixis, Inc.	9,450	$405,310
7	VRTX	Vertex Pharmaceuticals Inc / Ma	659	$294,269
8	ACAD	Acadia Pharmaceuticals Inc This page	12,923	$287,665

All Filings in ACAD

Export CSV

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$287,665	12,923	+30.6%	Shares	Sole	2026-05-04
2025-12-31	$264,348	9,897	—	Shares	Sole	2026-01-16
No filing history on record for this holder in this stock.